In vitro enantioselective study of the toxicokinetic effects of chiral fungicide Tebuconazole (cas 107534-96-3) in human liver microsomes
-
Add time:08/22/2019 Source:sciencedirect.com
Tebuconazole (cas 107534-96-3) (TEB) is a chiral triazole fungicide that is globally marketed and used as a racemic mixture to control plant pathogens. Due to its use as a racemic mixture, TEB may exhibit enantioselective toxicokinetics toward nontarget organisms, including humans. Therefore, the in vitro enantioselective metabolism of TEB by cytochrome P450 enzymes (CYP450) was studied using human liver microsomes, and the in vivo toxicokinetic parameters were predicted. A new enantioselective, reversed-phase LC-MS/MS method was developed and validated to analyze the enantiomers of TEB and its main metabolite, 1-hydroxytebuconazole (TEBOH). In vitro metabolic parameters were obtained, and in vitro-in vivo extrapolations were performed. Michaelis-Menten and atypical biphasic kinetic profiles were observed with a total intrinsic clearance ranging from 53 to 19 mL min−1 mg−1. The in vitro-in vivo extrapolation results showed that TEB first passage effect by the liver seems to be negligible, with hepatic clearance and extraction ratios ranging from 0.53 to 5.0 mL min−1 kg−1 and 2.7–25%, respectively. Preferential metabolism of (+)-TEB to rac-TEB and (−)-TEB was observed, with preferential production of (+)-TEBOH. Furthermore, reaction phenotyping studies revealed that, despite the low hepatic clearance in the first pass metabolism of TEB, multiple human CYP450 isoforms were involved in TEB metabolism when TEBOH enantiomers were generated, mainly CYP3A4 and CYP2C9, which makes TEB accumulation in the human body more difficult due to multiple metabolic pathways.
We also recommend Trading Suppliers and Manufacturers of Tebuconazole (cas 107534-96-3). Pls Click Website Link as below: cas 107534-96-3 suppliers
Prev:Chiral bioaccumulation behavior of Tebuconazole (cas 107534-96-3) in the zebrafish (Danio rerio)
Next:Biodegradation of fungicide Tebuconazole (cas 107534-96-3) by Serratia marcescens strain B1 and its application in bioremediation of contaminated soil) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Biodegradation of fungicide Tebuconazole (cas 107534-96-3) by Serratia marcescens strain B1 and its application in bioremediation of contaminated soil08/23/2019
- Chiral bioaccumulation behavior of Tebuconazole (cas 107534-96-3) in the zebrafish (Danio rerio)08/21/2019
- Preparation and characterization of Tebuconazole (cas 107534-96-3) metal-organic framework-based microcapsules with dual-microbicidal activity08/20/2019
- Research articleToxic effects of the fungicide Tebuconazole (cas 107534-96-3) on the root system of fusarium-infected wheat plants08/19/2019
- Insights into the effect on silkworm (Bombyx mori) cocooning and its potential mechanisms following non-lethal dose Tebuconazole (cas 107534-96-3) exposure08/18/2019
- Parental exposure to Tebuconazole (cas 107534-96-3) causes thyroid endocrine disruption in zebrafish and developmental toxicity in offspring08/17/2019
- Pubertal exposure to Tebuconazole (cas 107534-96-3) increases testosterone production via inhibiting testicular aromatase activity in rats08/16/2019
- Tebuconazole (cas 107534-96-3) induces triazole-resistance in Aspergillus fumigatus in liquid medium and soil08/15/2019
- Endocrine disrupting effects of Tebuconazole (cas 107534-96-3) on different life stages of zebrafish (Danio rerio)☆08/14/2019